N-cadherin monoclonal antibody as a therapeutic agent against chemoresistance in prostate cancer

被引：1
|
作者：
Shimomura, Tatsuya [1 ]
Kono, Evelyn [1 ]
Tran, Chao P. [1 ]
Yamashiro, Joyce [1 ]
Wainberg, Zev A. [1 ]
Reiter, Robert E. [1 ]
机构：
[1] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5052
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
    Tanaka, Hiroshi
    Kono, Evelyn
    Tran, Chau P.
    Miyazaki, Hideyo
    Yamashiro, Joyce
    Shimomura, Tatsuya
    Fazli, Ladan
    Wada, Robert
    Huang, Jiaoti
    Vessella, Robert L.
    An, Jaibin
    Horvath, Steven
    Gleave, Martin
    Rettig, Matthew B.
    Wainberg, Zev A.
    Reiter, Robert E.
    NATURE MEDICINE, 2010, 16 (12) : 1414 - U96
  • [2] Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
    Hiroshi Tanaka
    Evelyn Kono
    Chau P Tran
    Hideyo Miyazaki
    Joyce Yamashiro
    Tatsuya Shimomura
    Ladan Fazli
    Robert Wada
    Jiaoti Huang
    Robert L Vessella
    Jaibin An
    Steven Horvath
    Martin Gleave
    Matthew B Rettig
    Zev A Wainberg
    Robert E Reiter
    Nature Medicine, 2010, 16 : 1414 - 1420
  • [3] N-cadherin as a therapeutic target in cancer
    Mariotti, Agnese
    Perotti, Antonella
    Sessa, Cristiana
    Rueegg, Curzio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (04) : 451 - 465
  • [4] Monoclonal antibody against the 4th extracellular domain of N-cadherin affects FGF2 mediated pathways in prostate cancer
    Kono, Evelyn A.
    Tran, Chau P.
    Yamashiro, Joyce
    Shimomura, Tatsuya
    Reiter, Robert E.
    CANCER RESEARCH, 2011, 71
  • [5] N-cadherin—a target for prostate cancer therapy
    Lisa Richards
    Nature Reviews Clinical Oncology, 2011, 8 (2) : 63 - 63
  • [6] Development of fully humanized N-cadherin monoclonal antibodies for treatment of castration resistant prostate cancer
    Kono, Evelyn A.
    Kobayashi, Naoko
    Zettlitz, Kirstin
    Li, Keyu
    Yamashiro, Joyce
    Wang, Chun
    Wu, Anna
    Reiter, Robert E.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Co-targeting of AR and N-cadherin with Enzalutamide and 2A9 monoclonal antibody to treat castration resistant prostate cancer
    Kono, Evelyn A.
    Lee, Sean Hyung-Kwon
    Shimomura, Tatsuya
    Lin, Shu
    Yamashiro, Joyce
    Reiter, Robert E.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Efficacy of new developed N-cadherin monoclonal antibodies in combination with enzalutamide against castration-resistant prostate
    Kono, Evelyn A.
    Kobayashi, Naoko
    Zettlitz, Kirstin
    Yamashiro, Joyce
    Chun, Wang
    Hu, Della Z.
    Wu, Anna M.
    Reiter, Robert E.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 47 - 48
  • [9] Regulation of collective cell invasion of prostate cancer cells by N-cadherin
    Cui, Y.
    Blee, A.
    Yamada, S.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [10] N-cadherin switching occurs in high Gleason grade prostate cancer
    Jaggi, M
    Nazemi, T
    Abrahams, NA
    Baker, JJ
    Galich, A
    Smith, LM
    Balaji, KC
    PROSTATE, 2006, 66 (02): : 193 - 199
12345